Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
Janux Therapeutics, Inc. (NASDAQ:JANX), a $2.69 billion market cap biotech firm, noticed its President and CEO David Alan Campbell lately promote 5,000 shares of the corporate’s frequent inventory. The transaction, which happened on January 7, 2025, was performed below a…
Vicki L. Sato, a director at Vir Biotechnology, Inc. (NASDAQ:VIR), has offered a portion of her holdings within the firm. In response to a latest SEC submitting, Sato offered 10,960 shares of frequent inventory at a mean value of $12.52…
Nithrakashyap Arvind (NS:ARVN), Chief Know-how Officer of Rubrik, Inc. (NASDAQ:RBRK), an organization presently valued at $11.92 billion and displaying spectacular positive factors of over 70% previously yr, lately executed important inventory transactions as disclosed in a current SEC submitting. In…
In a current SEC submitting, Rubrik, Inc. (NASDAQ:RBRK), a cloud knowledge administration firm with a market capitalization of $11.92 billion, disclosed that its Chief Monetary Officer, Choudary Kiran Kumar, bought 1,800 shares of the corporate’s Class A Frequent Inventory. The…
Brian Ok. McCarthy, the Chief Income Officer of Rubrik, Inc. (NASDAQ:RBRK), lately offered a good portion of his holdings within the firm. Based on a Type 4 submitting with the Securities and Alternate Fee, McCarthy offered 65,517 shares of Rubrik’s…
Steve Krognes, a director at Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm with sturdy monetary well being indicators, not too long ago offered shares within the firm, in accordance with a submitting with the Securities and…
Alexander Schuth, the Chief Monetary Officer and Secretary of Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm, not too long ago bought shares valued at $308,290, in keeping with a Kind 4 submitting with the Securities and…
William Hoffman, a director at Inari Medical (TASE:PMCN), Inc. (NASDAQ:NARI), not too long ago bought a good portion of his holdings within the firm. In keeping with a submitting with the Securities and Change Fee, Hoffman bought a complete of…
On January 6 and seven, Ryan J. Watts, the President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), a $3.05 billion market cap biotech firm, executed a sequence of inventory gross sales totaling $750,955. The transactions concerned the sale of 29,266…
Carole Ho, the Chief Medical (TASE:PMCN) Officer of Denali Therapeutics Inc. (NASDAQ:DNLI), has just lately bought shares of the corporate’s frequent inventory, in keeping with a submitting with the Securities and Alternate Fee. On January 6 and seven, Ho bought…
